4//SEC Filing
ABRAMS CAPITAL MANAGEMENT, L.P. 4
Accession 0000899243-21-005693
CIK 0001756262other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:53 PM ET
Size
19.9 KB
Accession
0000899243-21-005693
Insider Transaction Report
Form 4
PAMET CAPITAL MANAGEMENT, LP
10% Owner
Transactions
- Sale
Common Stock
2021-02-09$33.32/sh−786,664$26,208,734→ 2,624,712 total(indirect: See Footnotes) - Sale
Common Stock
2021-02-08$26.24/sh−88,483$2,321,705→ 3,411,376 total(indirect: See Footnotes)
ABRAMS CAPITAL LLC
10% Owner
Transactions
- Sale
Common Stock
2021-02-08$26.24/sh−88,483$2,321,705→ 3,411,376 total(indirect: See Footnotes) - Sale
Common Stock
2021-02-09$33.32/sh−786,664$26,208,734→ 2,624,712 total(indirect: See Footnotes)
Abrams David C
10% Owner
Transactions
- Sale
Common Stock
2021-02-08$26.24/sh−88,483$2,321,705→ 3,411,376 total(indirect: See Footnotes) - Sale
Common Stock
2021-02-09$33.32/sh−786,664$26,208,734→ 2,624,712 total(indirect: See Footnotes)
Riva Capital Partners III, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-02-09$33.32/sh−786,664$26,208,734→ 2,624,712 total(indirect: See Footnotes) - Sale
Common Stock
2021-02-08$26.24/sh−88,483$2,321,705→ 3,411,376 total(indirect: See Footnotes)
PAMET CAPITAL MANAGEMENT LLC
10% Owner
Transactions
- Sale
Common Stock
2021-02-08$26.24/sh−88,483$2,321,705→ 3,411,376 total(indirect: See Footnotes) - Sale
Common Stock
2021-02-09$33.32/sh−786,664$26,208,734→ 2,624,712 total(indirect: See Footnotes)
Abrams Capital Partners II, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-02-08$26.24/sh−88,483$2,321,705→ 3,411,376 total(indirect: See Footnotes) - Sale
Common Stock
2021-02-09$33.32/sh−786,664$26,208,734→ 2,624,712 total(indirect: See Footnotes)
Riva Capital Management III, LLC
10% Owner
Transactions
- Sale
Common Stock
2021-02-08$26.24/sh−88,483$2,321,705→ 3,411,376 total(indirect: See Footnotes) - Sale
Common Stock
2021-02-09$33.32/sh−786,664$26,208,734→ 2,624,712 total(indirect: See Footnotes)
Footnotes (6)
- [F1]Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $26.23646 to $26.2918 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- [F2]Shares reported herein as beneficially owned by (i) Abrams Capital, LLC ("Abrams Capital") represent shares held for the account of Abrams Capital Partners II, L.P. ("ACP II") and other private investment funds for which Abrams Capital serves as general partner; and (ii) Riva Capital Management III, LLC ("RCM III") represent shares held for the account of Riva Capital Partners III, L.P. ("Riva III"), for which RCM III serves as general partner. Shares reported herein for Abrams Capital Management, L.P. (the "LP") and Abrams Capital Management, LLC (the "LLC") represent shares beneficially owned by private investment funds for which the LP serves as investment manager, including ACP II and Riva III. The LLC is the general partner of the LP. Shares reported herein for Mr. Abrams represent the above referenced shares reported for Abrams Capital, RCM III and the LLC. Mr. Abrams is the managing member of Abrams Capital, RCM III, and the LLC.
- [F3]Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest in such shares, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
- [F4]Of the shares sold on February 8, 2021, 41,063 shares were held for the account of ACP II; 36,868 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 36,868 shares; Abrams Capital may be deemed to beneficially own 48,595 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC.
- [F5]Represents the weighted average sale price of shares sold in a series of open market transactions on the transaction date at prices ranging from $33.04461 to $33.31643 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- [F6]Of the shares sold on February 9, 2021, 365,078 shares were held for the account of ACP II; 327,777 shares were held for the account of Riva III; RCM III may be deemed to beneficially own 327,777 shares; Abrams Capital may be deemed to beneficially own 432,043 shares; and all such shares may be deemed to have been beneficially owned by Mr. Abrams, the LP and the LLC.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001358706
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:53 PM ET
- Size
- 19.9 KB